Goldman Sachs
SOPH icon

Goldman Sachs’s SOPHiA GENETICS SOPH Stock Holding History

Goldman Sachs’s Portfolio SOPH Stock Details SOPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$285K Buy
57,628
+28,968
+101% +$141K ﹤0.01% 5919
2025
Q4 		$134K Buy
28,660
+1,453
+5% +$6.58K ﹤0.01% 6141
2025
Q3 		$130K Buy
27,207
+8,828
+48% +$30.3K ﹤0.01% 6033
2025
Q2 		$57K Buy
+18,379
New +$54.8K ﹤0.01% 5896

Other funds holding SOPH

GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $6.13B AUM 15.27% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
AWA
Alta Wealth Advisors Woburn, Massachusetts $308M AUM 27.87% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Goldman Sachs's SOPH Position: Q1 2026 in Review

Goldman Sachs increased its SOPHiA GENETICS (SOPH) stake by 101% in Q1 2026, buying an estimated $141K and bringing the position to 57,628 shares worth $285K. The position accounts for ﹤0.01% of the portfolio, ranked #5919.

Goldman Sachs first reported a position in SOPH in Q2 2025 and has held it in 4 quarters since. 49 funds tracked by Wall St. Rank hold SOPH as of Q1 2026.

  • Goldman Sachs held 57,628 shares of SOPHiA GENETICS worth $285K as of Q1 2026.
  • Goldman Sachs bought 28,968 SOPHiA GENETICS shares in Q1 2026, an estimated $141K.
  • SOPHiA GENETICS made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #5919 holding.
  • Goldman Sachs first reported a position in SOPHiA GENETICS in Q2 2025 and has held it in 4 quarters since.
  • 49 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.